XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component

Discover why State Street SPDR S&P Biotech ETF (XBI) is up 30% YTD, its unique high-beta structure, and key risks for biotech investors.

Zurich selects Arrowsight to help transform on-site construction safety across the U.S. with proven camera-enabled coaching solution

Zurich North America and Zurich Resilience Solutions (ZRS), leaders in construction insurance and risk engineering, announced ...